Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Legal Officer | October 01, 2026 | October 03, 2026 |
| TALPHERA, INC.ACRX · Entity 7102 | General Counsel and Secretary | April 16, 2018 | April 18, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,348 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 974 · Balance 39,965 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,668 · Balance 41,633 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 2,925 · Balance 44,558 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,496 · Balance 46,054 Row 5 · 2026-10-01 · Tax withholding · Disposed 3,706 · Balance 42,348 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 974 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,668 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 11,701 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 2,925 · Balance 11,701 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 8,978 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,496 · Balance 8,978 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
TALPHERA, INC.
Report date April 16, 2018 · Filed April 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.40 · Expires 2028-04-16 | Direct | 145,000 |
Reported balance
After 2018-04-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-04-16 · Grant · Acquired 145,000 · Balance 145,000 F1: Issued pursuant to the 2011 Equity Incentive Plan. F2: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued pursuant to the 2011 Equity Incentive Plan.
F2: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WAGEWORKS, INC.
Report date August 30, 2019 · Filed August 30, 2019
Section 16 reporting ended · disclosed 2019-08-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-08-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-08-30 · Disposition to issuer · Disposed 29,212 · Balance 0 F1: At the effective time of the merger, this equity grant was converted into RSUs of the acquiring company. |
Filing footnotes · ownership attribution and instrument terms
F1: At the effective time of the merger, this equity grant was converted into RSUs of the acquiring company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 13, 2023 Filed Dec 15, 2023 22:26 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 29,861 | $0.00 Strike: $28.37 | $0.00 |
DisclosureSEC source: 0001576280-23-000219 · wk-form4_1702679178.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,861 Underlying: COMMON STOCK · 29,861 shares Expires 2033-12-13 F1 · derivative.exercise_date: This represents a stock option granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:28 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000203 · wk-form4_1701732500.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,842 Underlying: COMMON STOCK · 263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:28 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 131 | $26.33 | $3,449.23 |
DisclosureSEC source: 0001576280-23-000203 · wk-form4_1701732500.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,602 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 23:28 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000203 · wk-form4_1701732500.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 3,895 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000175 · wk-form4_1696281943.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,688 Underlying: COMMON STOCK · 3,895 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 1,347 | $29.64 | $39,925.08 |
DisclosureSEC source: 0001576280-23-000175 · wk-form4_1696281943.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,470 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2023 Filed Oct 2, 2023 21:25 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 3,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000175 · wk-form4_1696281943.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2023 Filed Sep 11, 2023 21:58 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 302 | $33.72 | $10,183.44 |
DisclosureSEC source: 0001576280-23-000153 · wk-form4_1694469525.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,922 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000141 · wk-form4_1693947357.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,105 Underlying: COMMON STOCK · 263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 91 | $35.01 | $3,185.91 |
DisclosureSEC source: 0001576280-23-000141 · wk-form4_1693947357.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,224 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 20:56 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000141 · wk-form4_1693947357.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:46 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 12,173 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000089 · wk-form4_1686692745.xml · derivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,173 Underlying: COMMON STOCK · 12,173 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 15, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:46 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 18,260 | $0.00 Strike: $32.86 | $0.00 |
DisclosureSEC source: 0001576280-23-000089 · wk-form4_1686692745.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,260 Underlying: COMMON STOCK · 18,260 shares Expires 2033-06-09 F1 · derivative.exercise_date: This represents a stock option award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vests on June 9, 2024, and the remaining 67% of the shares vests in equal installments on each monthly anniversary of June 9, 2024, during the two-year period thereafter. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:49 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000074 · wk-form4_1686001735.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,368 Underlying: COMMON STOCK · 263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:49 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 91 | $31.39 | $2,856.49 |
DisclosureSEC source: 0001576280-23-000074 · wk-form4_1686001735.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,052 F1 · kind: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:49 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000074 · wk-form4_1686001735.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2023 Filed Apr 17, 2023 21:43 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 7,568 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000053 · wf-form4_168176781363663.xml · derivative · entry 4 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,706 Underlying: COMMON STOCK · 7,568 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units granted on August 8, 2022 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of April 15, 2022, and the remaining 75% annually during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 15, 2023 Filed Apr 17, 2023 21:43 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 1,074 | $24.50 | $26,313.00 |
DisclosureSEC source: 0001576280-23-000053 · wf-form4_168176781363663.xml · nonDerivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,880 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 15, 2023 Filed Apr 17, 2023 21:43 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 2,618 | $24.50 | $64,141.00 |
DisclosureSEC source: 0001576280-23-000053 · wf-form4_168176781363663.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,954 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 15, 2023 Filed Apr 17, 2023 21:43 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 7,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000053 · wf-form4_168176781363663.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000024 · wf-form4_167788044262602.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,631 Underlying: COMMON STOCK · 263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 108 | $29.36 | $3,170.88 |
DisclosureSEC source: 0001576280-23-000024 · wf-form4_167788044262602.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,004 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:54 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-23-000024 · wf-form4_167788044262602.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:11 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000114 · wf-form4_167027828764580.xml · derivative · entry 3 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,894 Underlying: COMMON STOCK · 263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:11 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 91 | $52.41 | $4,769.31 |
DisclosureSEC source: 0001576280-22-000114 · wf-form4_167027828764580.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,849 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:11 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000114 · wf-form4_167027828764580.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:26 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 15,583 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000096 · wf-form4_166803275567053.xml · derivative · entry 2 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,583 Underlying: COMMON STOCK · 15,583 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| November 07, 2022 Filed Nov 9, 2022 22:26 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 31,166 | $0.00 Strike: $47.20 | $0.00 |
DisclosureSEC source: 0001576280-22-000096 · wf-form4_166803275567053.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,166 Underlying: COMMON STOCK · 31,166 shares Expires 2032-11-06 F1 · derivative.exercise_date: This represents a stock option granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter. Read SEC document |
| September 09, 2022 Filed Sep 13, 2022 20:17 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 302 | $59.28 | $17,902.56 |
DisclosureSEC source: 0001576280-22-000081 · wf-form4_166310022622610.xml · nonDerivative · entry 3 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,677 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 01, 2022 Filed Sep 13, 2022 20:17 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 1,052 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000081 · wf-form4_166310022622610.xml · derivative · entry 4 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,157 Underlying: COMMON STOCK · 1,052 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each quarterly anniversary of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| September 01, 2022 Filed Sep 13, 2022 20:17 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 364 | $49.07 | $17,861.48 |
DisclosureSEC source: 0001576280-22-000081 · wf-form4_166310022622610.xml · nonDerivative · entry 2 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,979 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 01, 2022 Filed Sep 13, 2022 20:17 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCOMMON STOCK | 1,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000081 · wf-form4_166310022622610.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:42 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 30,274 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000060 · wf-form4_166016414460734.xml · derivative · entry 2 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,274 Underlying: COMMON STOCK · 30,274 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on April 15, 2023, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of April 15, 2023, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| August 08, 2022 Filed Aug 10, 2022 20:42 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 60,548 | $0.00 Strike: $54.50 | $0.00 |
DisclosureSEC source: 0001576280-22-000060 · wf-form4_166016414460734.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,548 Underlying: COMMON STOCK · 60,548 shares Expires 2032-08-08 F1 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to such award on April 3, 2023, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of April 3, 2023, during the three-year period thereafter. Read SEC document |
| April 15, 2022 Filed Apr 19, 2022 20:40 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 1,102 | $71.99 | $79,332.98 |
DisclosureSEC source: 0001576280-22-000018 · wf-form4_165040080476333.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,291 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:13 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRESTRICTED STOCK UNITS · Derivative | 4,209 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-21-000100 · wf-form4_163605677149062.xml · derivative · entry 2 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,209 Underlying: COMMON STOCK · 4,209 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each quarterly anniversary of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:13 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 8,418 | $0.00 Strike: $117.61 | $0.00 |
DisclosureSEC source: 0001576280-21-000100 · wf-form4_163605677149062.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,418 Underlying: COMMON STOCK · 8,418 shares Expires 2031-11-01 F1 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to such award on September 1, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of September 1, 2022, during the three-year period thereafter. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 21:00 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 433 | $130.85 | $56,658.05 |
DisclosureSEC source: 0001576280-21-000089 · wf-form4_163156684263122.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,393 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 23:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCOMMON STOCK | 1,077 | $159.20 | $171,458.40 |
DisclosureSEC source: 0001576280-21-000042 · wf-form4_161887328705227.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,826 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| September 11, 2020 Filed Dec 18, 2020 00:23 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantCOMMON STOCK | 3,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-20-000004 · wf-form4_160825100741956.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,903 Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 24,824 | $0.00 Strike: $82.83 | $0.00 |
DisclosureSEC source: 0001628280-20-010609 · wf-form4_159562568781342.xml · derivative · entry 2 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,824 Underlying: COMMON STOCK · 24,824 shares Expires 2030-07-21 F1 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to such award on April 15, 2021, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of April 15, 2021, during the three-year period thereafter. Read SEC document |
| July 22, 2020 Filed Jul 24, 2020 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantCOMMON STOCK | 12,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-010609 · wf-form4_159562568781342.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,412 Read SEC document |
| August 30, 2019 Filed Aug 30, 2019 19:28 UTC | WAGEWORKS, INC. WAGE · Entity 155161 | Disposition to issuerRestricted Stock Units · Derivative | 29,212 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-002042 · form.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,212 shares Expires not disclosed F1 · derivative.expiration_date: At the effective time of the merger, this equity grant was converted into RSUs of the acquiring company. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 20:42 UTC | WAGEWORKS, INC. WAGE · Entity 155161 | GrantRestricted Stock Units - Granted on July 1, 2019 · Derivative | 29,211 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-19-001695 · form.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · SVP, GC & Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,211 Underlying: Common Stock · 29,211 shares Expires 2029-07-01 F1 · derivative.exercise_date: All of the restricted stock units are vesting in equal annual installments on each of the first 4 anniversaries of grant. F2 · derivative.underlying: Each restricted stock unit represents a contingent right to receive one share of WageWorks Inc. common stock. Read SEC document |
| April 16, 2018 Filed Apr 18, 2018 21:07 UTC | TALPHERA, INC. ACRX · Entity 7102 | GrantStock Option (Right to Buy) · Derivative | 145,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001209191-18-025406 · doc4.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock · 145,000 shares Expires 2028-04-16 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.